Company intelligence / Profile preview
GeneCure Biotechnologies
Peachtree Corners/Norcross*, Georgia, USAgenecure.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
GeneCure has demonstrated that its SimVec lentiviral platform can safely deliver genes to human cells. Its lead program, a therapeutic HIV vaccine, showed durable viral load control and reduced immune activation in a first-in-human trial. The company also has a hepatitis C vaccine in Phase I trials and is developing a therapeutic COVID-19 vaccine using the same platform.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Lentiviral vectorsTherapeutic/prophylactic vaccines
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
No specific partnerships named publicly as active; the company's stated strategy is to partner with established pharmaceutical companies for late-stage development and commercialization.
Beyond the preview
Go deeper on GeneCure Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GeneCure Biotechnologies.